Othman, Zahiruddin and Jaapar, Sharifah Zubaidiah Syed and Husain, Maruzairi and Yasin, Mohd Azhar Mohd (2016) Use of Queatiapine in Treatment of Unremitting Anxiety: A Case Report of Schizophrenia Prodrome. International Medical Journal, 23 (6). pp. 624-625. ISSN 13412051
|
PDF
Download (587kB) | Preview |
Abstract
Objective: A 21-year-old man who presented with a 17-month history of unremitting anxiety associated with panic attacks was studied. Result: The anxiety with panic attacks did not abate with escitalopram 15 mg nocte and alprazolam 0.5 mg tds. At month 3, the patient reported low mood and unexplained sexual arousal in addition to the unremitting anxiety symptoms. His condition fairly improved with addition of quetiapine. At month 17, transition to psychotic disorder occurred when the patient experienced hallucinations for the first time. Quetiapine was increased to 500 mg nocte and the anxiety symptoms improved tremendously before he relapsed 6 months later due to poor compliance. Conclusion: Unremitting anxiety with depression can be a dominant feature during the schizophrenia prodrome. Atypical antipsychotic quetiapine is an interesting treatment option due to its status as approved adjunctive treatment for major depressive disorder and promising efficacy for generalized anxiety disorder.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | depression, prodrome, pseudoneurotic, early intervention, quetiapine |
| Subjects: | R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry |
| Divisions: | Kampus Kesihatan (Health Campus) > Pusat Pengajian Sains Perubatan (School of Medical Sciences) > Article Zoom Profil Pakar (Expert Profile) > Zahiruddin Othman (Medical Sciences) |
| Depositing User: | Administrator Automasi |
| Date Deposited: | 11 Apr 2019 08:49 |
| Last Modified: | 11 Apr 2019 08:49 |
| URI: | http://eprints.usm.my/id/eprint/44056 |
Actions (login required)
 |
View Item |
